{"transactions":[{"id":727630,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35651,"kind":"person","name":"Wildman Daniel George","position":1,"cik":"0001952679","reported_name":"Wildman Daniel George","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2026-06-24T14:03:57.000Z","date":"2026-06-22","kind":"grant","planned":false,"acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying the RSUs will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares underlying the RSUs will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates."}],"balance_after":8000,"derivative":{"underlying":"Ordinary Shares","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001437749-26-021519","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774926021519/rdgdoc.xml","form_type":"4"}},{"id":727629,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35651,"kind":"person","name":"Wildman Daniel George","position":1,"cik":"0001952679","reported_name":"Wildman Daniel George","relationship":{"director":true}}],"security":"Stock Option (right ot buy)","published_at":"2026-06-24T14:03:57.000Z","date":"2026-06-22","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates."}],"balance_after":10000,"derivative":{"exercise_price":34.99,"expiration_date":"2036-06-22","underlying":"Ordinary Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001437749-26-021519","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774926021519/rdgdoc.xml","form_type":"4"}},{"id":985068,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35651,"kind":"person","name":"Wildman Daniel George","position":1,"cik":"0001952679","reported_name":"Wildman Daniel George","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2025-12-01T21:44:50.000Z","date":"2025-11-26","kind":"exercise","planned":false,"acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer"}],"balance_after":6000,"derivative":{"underlying":"Ordinary Shares","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001437749-25-036555","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925036555/rdgdoc.xml","form_type":"4"}},{"id":985067,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35651,"kind":"person","name":"Wildman Daniel George","position":1,"cik":"0001952679","reported_name":"Wildman Daniel George","relationship":{"director":true}}],"security":"ordinary shares","published_at":"2025-12-01T21:44:50.000Z","date":"2025-11-26","kind":"exercise","planned":false,"acquired":true,"shares":2000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer"}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001437749-25-036555","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925036555/rdgdoc.xml","form_type":"4"}},{"id":1054545,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35651,"kind":"person","name":"Wildman Daniel George","position":1,"cik":"0001952679","reported_name":"Wildman Daniel George","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2025-08-27T20:39:47.000Z","date":"2025-08-26","kind":"grant","planned":false,"acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying the RSUs will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares underlying the RSUs will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates."}],"balance_after":8000,"derivative":{"underlying":"Ordinary Shares","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001437749-25-027883","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925027883/rdgdoc.xml","form_type":"4"}},{"id":1054544,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35651,"kind":"person","name":"Wildman Daniel George","position":1,"cik":"0001952679","reported_name":"Wildman Daniel George","relationship":{"director":true}}],"security":"Stock Option (right ot buy)","published_at":"2025-08-27T20:39:47.000Z","date":"2025-08-26","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates."}],"balance_after":10000,"derivative":{"exercise_price":19.5,"expiration_date":"2035-08-26","underlying":"Ordinary Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001437749-25-027883","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925027883/rdgdoc.xml","form_type":"4"}},{"id":1437866,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35651,"kind":"person","name":"Wildman Daniel George","position":1,"cik":"0001952679","reported_name":"Wildman Daniel George","relationship":{"director":true}}],"security":"Stock Option (right ot buy)","published_at":"2024-08-08T13:10:33.000Z","date":"2024-08-06","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates."}],"balance_after":10000,"derivative":{"exercise_price":15.16,"expiration_date":"2034-08-06","underlying":"Ordinary Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001437749-24-025297","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774924025297/rdgdoc.xml","form_type":"4"}},{"id":1784654,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35651,"kind":"person","name":"Wildman Daniel George","position":1,"cik":"0001952679","reported_name":"Wildman Daniel George","relationship":{"director":true}}],"security":"Stock Option (right ot buy)","published_at":"2023-09-08T19:42:44.000Z","date":"2023-09-07","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option will vest in equal quarterly installments over a period of one year."}],"balance_after":10000,"derivative":{"exercise_price":16.85,"expiration_date":"2033-09-07","underlying":"Ordinary Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001437749-23-025483","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774923025483/rdgdoc.xml","form_type":"4"}},{"id":2121178,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35651,"kind":"person","name":"Wildman Daniel George","position":1,"cik":"0001952679","reported_name":"Wildman Daniel George","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2022-11-09T22:57:03.000Z","date":"2022-11-08","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option vest in equal quarterly installments for 12 quarters"}],"balance_after":20000,"derivative":{"exercise_price":11.88,"expiration_date":"2032-11-08","underlying":"Ordinary Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001437749-22-026635","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774922026635/rdgdoc.xml","form_type":"4"}}]}